Civil Law Study on Genetic Medicine - Focusing on the English Law and the Swedish Law

基因医学民法研究——以英国法和瑞典法为中心

基本信息

批准号：
17530067
负责人：
ISOGAWA Naoyuki
金额：
$ 2.11万
依托单位：
Kyushu University
依托单位国家：
日本
项目类别：
Grant-in-Aid for Scientific Research (C)
财政年份：
2005
资助国家：
日本
起止时间：
2005 至 2006
项目状态：
已结题

来源：
https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-17530067/
关键词：
genetic medicine genetic information medical injury the patient doctor relationship patient's right English medical law medical law 遺伝子医療と法遺伝情報と法医事民法

项目摘要

The aims of this medico-legal research gather around the comparative legal study on gene tic medicine as a whole, including genetic testing genetic diagnosis, gene therapy, and clinical research on gene therapy. This research has also a special linkage with my former researches on the patient/doctor relationship. While continuously pursuing a study on the English medical law and the Swedish medical law as my preceding researches, this project newly set its course to the fundamental problems arising from the accidents/incidents during the medical practices using gene technology. After the basic study on the general backgrounds and practices of genetic medicine, the main issues to be tackled with were realized as follows. 1. Peculiarity of gene medicine: medical practice with genetic technique has some unique points contrasting to normal (non-genetic) medical practices or not. 2. Difference of stages on genetic medicine: something specials to be considered are found between genetic testing/therapy and genetic research or not. 3. Special problems: a genetic practice (for example, PGD) has own legal matters or not. In process of this research I had opportunities to visit and study further at the main British medico-legal centers including Cardiff Law School and at Uppsala University in Sweden, and could manage to collect so many essential materials on medical law as a whole. Main results from this research are as follows. 1. Genetic medicine basically has common legal settings with normal (non-genetic) medical practices except for genetic information. 2. In case of genetic research the patient/supplier of materials must be highly protected. 3. Special problems: some cases (including PGD case, right-not-to-know case) are worth studying further. As the next research schedule, inter alia, a promotion of fundamental study on the legal aspects of the genetic information, for instance, should be highly expected along the line of these research projects.

这项医学法研究的目的围绕整个基因技术医学的比较法律研究，包括基因检测遗传诊断，基因治疗和基因治疗临床研究。这项研究还与我以前关于患者/医生关系的研究有着特别的联系。作为我先前的研究，该项目不断地探讨《英国医学法》和《瑞典医学法》的研究，但该项目将其在使用基因技术的医学实践中发生的事故/事件引起的基本问题新设置为基本问题。在对遗传医学的一般背景和实践的基础研究之后，要解决的主要问题如下所见。 1。基因医学的特殊性：遗传技术的医学实践与正常（非遗传）医学实践形成鲜明对比。 2。遗传医学阶段的差异：在基因测试/治疗和遗传研究之间发现了一些特殊的东西。 3。特殊问题：遗传实践（例如，PGD）是否有自己的法律问题。在这项研究的过程中，我有机会在包括加的夫法学院和瑞典乌普萨拉大学在内的英国主要法律中心进行进一步研究，并可以设法收集许多有关整个医学法的重要材料。这项研究的主要结果如下。 1。基本上，除了遗传信息外，基本上具有常规（非遗传）医学实践的常见法律环境。 2。在遗传研究的情况下，必须高度保护材料的患者/材料供应商。 3。特殊问题：某些案件（包括PGD案例，不知道的情况）值得进一步研究。作为下一个研究时间表，例如，在这些研究项目的方面，应该高度期望对遗传信息法律方面的基础研究提升。